Your Article Summary
Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study
BMC Cancer, 07/02/09
Kim J et al. - In a study to examine the association between fish and fish omega-3 fatty acids intake with the risk of breast cancer in a case-control study of Korean women, these results suggest that high consumption of fatty fish is associated with a reduced risk for breast cancer, and that intake of omega-3 fatty acids from fish is inversely associated with postmenopausal breast cancer risk.
Methods- 358 incident breast cancer pts and 360 controls were recruited with no history of malignant neoplasm.
- Study participants were given a 103-item food intake frequency questionnaire to determine their dietary consumption of fish (fatty and lean fish) and omega-3 fatty acids derived from fish (eicosapentaenoic acid [EPA], and docosahexaenoic acid [DHA]).
- Using a multivariate logistic regression model, high intake of fatty fish was associated with reduced risk for breast cancer in both pre- and postmenopausal women.
- Reductions in breast cancer risk were observed among postmenopausal subjects who consumed more than 0.101 g of EPA and 0.213 g of DHA from fish per day vs the reference group who consumed <0.014 g of EPA and <0.037 g of DHA per day.
- Among premenopausal women, there was a significant reduction in breast cancer risk for the highest intake quartiles of omega-3 fatty acids vs the reference group who consumed the lowest quartile of intake.
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 11/30/09
Relevance Score: 86%%
Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Annals of Internal Medicine, 11/19/09
Relevance Score: 84%%
Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: The UK MARIBS study
Breast Cancer Research, 11/17/09
Relevance Score: 84%%
Breast-feeding the last born child and risk of ovarian cancer
Cancer Causes and Control, 11/16/09
Relevance Score: 84%%
Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: A meta-analysis involving 46,281 subjects
Breast Cancer Research and Treatment, 11/30/09
Relevance Score: 83%%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Bevacizumab and breast cancer: current therapeutic progress and future perspectives
Expert Review of Anticancer Therapy, 12/04/09
Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis
Cancer Treatment Reviews, 12/04/09
Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer
Cancer Treatment Reviews, 12/04/09

See Latest Articles